Mossenta M - Search Results

1

Role of N-glycosylation on Zika virus E protein secretion, viral assembly and infectivity.

Mossenta M, Marchese S, Poggianella M, Slon Campos JL, Burrone OR. Mossenta M, et al. Biochem Biophys Res Commun. 2017 Oct 28;492(4):579-586. doi: 10.1016/j.bbrc.2017.01.022. Epub 2017 Jan 7. Biochem Biophys Res Commun. 2017. PMID: 28069378

2

DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.

Slon Campos JL, Poggianella M, Marchese S, Mossenta M, Rana J, Arnoldi F, Bestagno M, Burrone OR. Slon Campos JL, et al. Among authors: mossenta m. PLoS One. 2017 Jul 25;12(7):e0181734. doi: 10.1371/journal.pone.0181734. eCollection 2017. PLoS One. 2017. PMID: 28742857 Free PMC article.

3

Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.

Slon Campos JL, Marchese S, Rana J, Mossenta M, Poggianella M, Bestagno M, Burrone OR. Slon Campos JL, et al. Among authors: mossenta m. Sci Rep. 2017 Apr 19;7(1):966. doi: 10.1038/s41598-017-01097-5. Sci Rep. 2017. PMID: 28424472 Free PMC article.

4

Novel immunotherapeutic approaches for hepatocellular carcinoma treatment.

Busato D, Mossenta M, Baboci L, Di Cintio F, Toffoli G, Dal Bo M. Busato D, et al. Among authors: mossenta m. Expert Rev Clin Pharmacol. 2019 May;12(5):453-470. doi: 10.1080/17512433.2019.1598859. Epub 2019 Apr 14. Expert Rev Clin Pharmacol. 2019. PMID: 30907177 Review.

5

New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma.

Mossenta M, Busato D, Baboci L, Cintio FD, Toffoli G, Bo MD. Mossenta M, et al. Cancers (Basel). 2019 Jul 31;11(8):1086. doi: 10.3390/cancers11081086. Cancers (Basel). 2019. PMID: 31370258 Free PMC article. Review.

6

Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies.

Mossenta M, Busato D, Dal Bo M, Toffoli G. Mossenta M, et al. Cancers (Basel). 2020 Jun 23;12(6):1668. doi: 10.3390/cancers12061668. Cancers (Basel). 2020. PMID: 32585931 Free PMC article. Review.

7

A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients.

Bedon L, Dal Bo M, Mossenta M, Busato D, Toffoli G, Polano M. Bedon L, et al. Among authors: mossenta m. Int J Mol Sci. 2021 Jan 22;22(3):1075. doi: 10.3390/ijms22031075. Int J Mol Sci. 2021. PMID: 33499054 Free PMC article.

8

Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies.

Mossenta M, Busato D, Dal Bo M, Macor P, Toffoli G. Mossenta M, et al. Int J Mol Sci. 2022 Sep 2;23(17):10038. doi: 10.3390/ijms231710038. Int J Mol Sci. 2022. PMID: 36077433 Free PMC article. Review.

9

The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma.

Busato D, Mossenta M, Dal Bo M, Macor P, Toffoli G. Busato D, et al. Among authors: mossenta m. Int J Mol Sci. 2022 Sep 7;23(18):10279. doi: 10.3390/ijms231810279. Int J Mol Sci. 2022. PMID: 36142190 Free PMC article. Review.

10

Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma.

Mossenta M, Argenziano M, Capolla S, Busato D, Durigutto P, Mangogna A, Polano M, Sblattero D, Cavalli R, Macor P, Toffoli G, Dal Bo M. Mossenta M, et al. Nanomedicine (Lond). 2025 Jan 15:1-16. doi: 10.1080/17435889.2025.2452154. Online ahead of print. Nanomedicine (Lond). 2025. PMID: 39815170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters